Preclinical research points to a promising new treatment option for pancreatic cancer patients
Preclinical research published in the Journal for ImmunoTherapy of Cancer points to a promising new treatment option for people with pancreatic cancer.
Stay updated with breaking news from Azeddine Atfi. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Preclinical research published in the Journal for ImmunoTherapy of Cancer points to a promising new treatment option for people with pancreatic cancer.
Most patients are diagnosed at an advanced stage when the disease is already inoperable and there are no effective therapies. Extensive research has demonstrated that mutations in the KRAS gene play an enormous role in the formation and growth of pancreatic cancer.
New research out of VCU Massey Cancer Center points to the inactivation of a previously unidentified gene as a likely culprit in the development of pancreatic cancer.
A previously unknown gene's inactivation is suggested as a possible cause of pancreatic cancer by a recent study from the VCU Massey Cancer Center.
Get latest articles and stories on Health at LatestLY. Study revealed the possible cause of pancreatic cancer. The findings hold implications for the targeted treatment of pancreatic ductal adenocarcinoma (PDAC), which accounts for the vast majority of all pancreatic tumors and is the fourth-leading cause of cancer-related deaths worldwide. Health News | Researchers Find New Genetic Cause for Pancreatic Cancer.